Tuesday, November 28, 2023
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
C.N.H. Long Professor of Immunobiology and Medicine (Endocrinology)
Yale School of Medicine
New Haven, Connecticut
American Diabetes Association Eminent Scholar for Diabetes Research
Jeffrey Keene Family Professor
Director, UF Diabetes Institute
Departments of Pathology and Pediatrics
The University of Florida
Gainesville, Florida
Assistant Professor of Pediatrics
Barbara Davis Center for Diabetes
University of Colorado School of Medicine
Aurora, Colorado
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
Physicians - maximum of 1.25 AMA PRA Category 1 Credit(s)™
ABIM Diplomates - maximum of 1.25 ABIM MOC points
Nurses - 1.25 ANCC Contact Hour(s) (0.5 contact hours are in the area of pharmacology)
IPCE - 1.25 Interprofessional Continuing Education (IPCE) credit
This activity is intended for diabetologists, endocrinologists, pediatricians, primary care physicians, and others involved in screening, diagnosis, monitoring, and management of patients with T1D.
The goal of this activity is for learners to be better able to improve their ability to identify those at high-risk of developing T1D and educate these patients and caregivers about the stages of T1D, including currently available interventions.
Upon completion of this activity, participants will:
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
C.N.H. Long Professor of Immunobiology and Medicine (Endocrinology)
Yale School of Medicine
New Haven, Connecticut
American Diabetes Association Eminent Scholar for Diabetes Research
Jeffrey Keene Family Professor
Director, UF Diabetes Institute
Departments of Pathology and Pediatrics
The University of Florida
Gainesville, Florida
Assistant Professor of Pediatrics
Barbara Davis Center for Diabetes
University of Colorado School of Medicine
Aurora, Colorado
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
This activity was planned by and for the healthcare team, and learners will receive 1.25 Interprofessional Continuing Education (IPCE) credit for learning and change.
Awarded 1.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.50 contact hours are in the area of pharmacology.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / ABIM MOC / CE Released: 6/30/2023
Valid for credit through: 6/30/2024, 11:59 PM EST
processing....
Editor’s Note: On June 25, 2023, during the 83rd Scientific Sessions of the American Diabetes Association (ADA), updates to the ADA’s Standards of Care in Diabetes – 2023, were announced and published online, endorsing the use of teplizumab for delaying the onset of type 1 diabetes in individuals older than 8 years old with stage 2 type 1 diabetes. In addition, the importance of screening programs for detection of autoantibodies as well as the potential harmful effect of delayed screening were also stressed.
Please answer these questions to complement your learning experience.
